Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Enrolling by invitation · Phase 3

Conditions studied: Irritable Bowel Syndrome With Constipation (IBS-C)

In brief

Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.

Key facts

Study ID
NCT05905926
Run by
Ardelyx
People needed
150
Starts
2023-02-17
Expected to finish
2031-10-01
Last updated by the study team
2026-06-04

Who can join

Age: 6 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.